Non-Pharmacological Option in Postoperative Pain: Pilot Study of Intraoperative Pulsed Radiofrequency

术后疼痛的非药物治疗选择:术中脉冲射频消融的初步研究

阅读:2

Abstract

OBJECTIVES: Postoperative pain remains a discomfort for patients undergoing thoracic surgery despite advances in minimally invasive techniques. Pulsed radiofrequency (PRF) is a minimally invasive neuromodulation method used for chronic pain. This pilot study aimed to evaluate the efficacy of intraoperative PRF (iPRF) as an adjunct to conventional analgesia (thoracic epidural analgesia [TEA] or intercostal nerve block [INB]) in alleviating postoperative pain and analgesic use following minimally invasive thoracic surgery. METHODS: A prospective pilot cohort was compared with historical controls at a single tertiary hospital in Japan. The iPRF group (n = 30) received PRF targeting the intercostal nerves intraoperatively in addition to standard analgesia. The control group comprised retrospective patients who received standard analgesia alone. Patients were stratified into TEA and INB subgroups according to procedure type. The primary end-point was the proportion of patients requiring additional analgesics. Secondary end-points included pain scores (numerical rating scale [NRS]), incidence of intercostal neuralgia, and side effects. RESULTS: Intraoperative PRF significantly reduced the need for additional analgesics in TEA (26.7% vs 60.0%, P = .027) and INB (6.7% vs 42.1, P = .020) subgroups. In the TEA group, iPRF also reduced the proportion of patients reporting NRS ≥4 following drain removal (26.7% vs 60.0%, P = .027). The incidence of analgesic-induced side effects was significantly lower in the iPRF INB group (0% vs 28.6%, P = .031). No adverse events were associated with iPRF. CONCLUSIONS: Intraoperative PRF may be a safe and effective adjunctive method for postoperative pain alleviation in thoracic surgery, reducing analgesic requirements. CLINICAL REGISTRATION NUMBER: The Institutional Review Board of St. Luke's International Hospital approved the study (No. 24-R085) on September 9, 2024.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。